47.73.Z - Retail sale of pharmaceutical products
21.10.Z - Manufacture of basic pharmaceutical products
21.20.Z - Manufacture of pharmaceutical preparations and other pharmaceutical products
47.29.Z - Retail trade
47.74.Z - Retail sale of medical and orthopedic products
47.75.Z - Retail sale of cosmetics and toiletries
73.20.Z - Market research and public opinion polling
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Profit (loss) on sale | -0,1 | 0,1 | 0,5 | 295,5 |
Gross profit (loss) | -0,1 | 0,1 | 0,5 | 291,2 |
EBITDA | -0 | 0,1 | 0,5 | 250,1 |
Short time liabilities | 0,9 | 1,5 | 2,7 | 80,8 |
Other operating costs | 0 | 0 | 0,1 | 1008 |
Equity capital | -0,5 | -0,4 | 0 | 109,6 |
Operating profit (EBIT) | -0,1 | 0,1 | 0,5 | 281,2 |
Assets | 1,4 | 2 | 3,3 | 69,8 |
Net profit (loss) | -0,1 | 0,1 | 0,5 | 291,2 |
Cash | 0,4 | 0,5 | 0,4 | -24,1 |
Net income from sale | 5 | 9,7 | 18,9 | 93,8 |
Liabilities and provisions for liabilities | 1,9 | 2,4 | 3,3 | 38,1 |
Working assets | 1,3 | 1,8 | 3,2 | 73,2 |
Other income costs | 0 | 0 | 0,1 | 700,3 |
Depreciation | 0 | 0 | 0 | 37,2 |
% | % | % | p.p. | |
Profitability of capital | 11,3 | -28 | 1139,5 | 1167,5 |
Equity capital to total assets | -38,7 | -21,5 | 1,2 | 22,7 |
Gross profit margin | -1,2 | 1,2 | 2,5 | 1,3 |
EBITDA Margin | -0,7 | 1,5 | 2,7 | 1,2 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 66 | 56 | 52 | -4 |
Current financial liquidity indicator | 1.424822449684143 | 1.2189635038375854 | 1.1673423051834106 | 0 |
Net dept to EBITDA | -19.186277389526367 | 2.896317958831787 | 0.4602733254432678 | -2,4 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane